Margin of Interest It would appear that PLI's competitive market marginalized to it favor...lol.
By Ryan Flinn - Aug 24, 2012 5:46 AM PT
https://www.bloomberg.com/news/2012-08-23/bristol-myers-drops-hepatitis-c-drug-after-patient-death.html
:)
Bristol-Myers will take a charge of $1.8 billion in the third quarter related to research and development of the therapy, the New York-based company said in a regulatory filing today. The drugmaker suspended testing the medicine, known as BMS-986094, on Aug. 1 after a patient developed heart failure.
:)
Another billion dollar blunder....next...PLI...lol.